Document:

Exhibit
10.19

     

    COMMON
STOCK PURCHASE AGREEMENT

     

    This
Common Stock Purchase Agreement (this “Agreement”) is dated
as of December  30, 2009, by and among Oragenics, Inc, a Florida
corporation (the “Company) and Carol E.
Martin (“Martin”), The Koski
Family Limited Partnership, a Texas limited partnership (“KFLP”) and the
individuals or entities set forth on the signature pages of this Agreement (each
a “Purchaser”
and collectively, the “Purchasers”).

     

    WHEREAS, the Company desires
to raise a minimum of $2,500,000 and a maximum of $3,000,000 (which maximum
amount may be increased by the Company’s Board of Directors in its discretion)
in a private placement of shares of Common Stock of the Company solely to
accredited investors.

     

    WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to applicable exemptions
from registration under the Securities Act of 1933, the Company desires to issue
and sell to the Purchasers, and the Purchasers desire to purchase from the
Company shares of Common Stock of the Company in the private placement as set
forth herein.

     

    NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good
and valuable consideration the receipt and adequacy of which are hereby
acknowledged, the parties agree as follows:

     

    ARTICLE
I

    DEFINITIONS

     

    Section
1.1.  Definitions.  In
addition to the terms defined elsewhere in this Agreement, for all purposes of
this Agreement, the following terms have the meanings indicated in this Section
1.1:

     

    “Action” shall have
the meaning ascribed to such term in Section 3.1(j).

     

    “Affiliate” means any
Person that, directly or indirectly through one or more intermediaries, controls
or is controlled by or is under common control with a Person as such terms are
used in and construed under Rule 144.  With respect to a Purchaser,
any investment fund or managed account that is managed on a discretionary basis
by the same investment manager as Purchaser will be deemed to be an Affiliate of
Purchaser.

     

    “Business Day” means
any day except Saturday, Sunday and any day which shall be a federal legal
holiday or a day on which banking institutions in the State of New York are
authorized or required by law or other governmental action to
close.

     

    “Closing” means the
closing of the purchase and sale of the Shares pursuant to Section
2.1.

     

    “Closing Date” means
the date of the Closing.

     

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    “Commission” means the
Securities and Exchange Commission.

     

    “Common Stock” means
the common stock of the Company, $0.001 par value per share, and any securities
into which such common stock may hereafter be reclassified.

     

    “Disclosures” means
the Disclosure Schedules, if any, attached as Annex I
hereto.

     

    “Exchange Act” means
the Securities Exchange Act of 1934, as amended.

     

    “Intellectual Property
Rights” shall have the meaning ascribed to such term in Section
3.1(o).

     

    “Liens” means a lien,
charge, security interest, encumbrance, right of first refusal or other
restriction.

     

    “Material Adverse
Effect” shall have the meaning ascribed to such term in Section
3.1(b).

     

    “Material Permits”
shall have the meaning ascribed to such term in Section 3.1(m).

     

    “Person” means an
individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any
kind.

     

    “Purchase Price”
means, as to the Purchasers and the Closing, the amounts set forth below
Purchaser’s signature block on the signature page hereto, in United States
dollars and in immediately available funds. This amount is $0.25 per share of
Common Stock.

     

    “SEC Reports” shall
have the meaning ascribed to such term in Section 3.1(h).

     

    “Securities” means the
Shares.

     

    “Securities Act” means
the Securities Act of 1933, as amended.

     

    “Shares” means the
shares of Common Stock, of which are being issued and sold by the Company to the
Purchasers at the Closing.

     

    “Trading Market” means
the following markets or exchanges on which the Common Stock may be listed or
quoted for trading on the date in question: the Nasdaq Capital Market, the
American Stock Exchange, the New York Stock Exchange, the Nasdaq National Market
or the OTC Bulletin Board (“OTC-BB”).

     

    “Transaction
Documents” means this Agreement and any other documents or written
agreements executed by the Company and the Purchasers in connection with the
transactions contemplated hereunder.

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    ARTICLE
II

    PURCHASE
AND SALE

     

    Section
2.1.  Purchase and Sale of Common
Stock and Closing.  At the Closing, the Purchasers shall
purchase, severally and not jointly, and the Company shall issue and sell to the
Purchasers that number of shares of Common Stock as set forth opposite each
Purchaser’s name on the signature page hereto for the aggregate purchase price
as set forth opposite each Purchaser’s name on the signature page
hereto.  The Closing shall occur on the date of this Agreement at the
offices of Shumaker, Loop & Kendrick, LLP, 101 Kennedy Boulevard, Suite
2800, Tampa, Florida 33602, or such other time and/or location as the parties
shall mutually agree.

     

    Section
2.2.  Closing Deliveries and
Conditions.

     

    (a)  At
the Closing, the Company shall be obligated to deliver or cause to be delivered
to the Purchasers:

     

    (i)          Instructions
to the transfer agent of the Company to issue stock certificates in the name of
the respective Purchaser evidencing the Shares being sold to the respective
Purchaser; and

     

    (ii)         And
a duly executed signature page to this Agreement.

     

    (b)  At
the Closing, the Purchasers shall deliver or cause to be delivered to the
Company the following:

     

    (i)          the
Purchase Price by wire transfer to the trust account of the Company’ legal
counsel, Shumaker, Loop & Kendrick, LLP; and

     

    (ii)         A
duly executed signature page to this Agreement.

     

    (c)  All
representations and warranties of the other party contained herein shall be true
and correct as of the Closing Date (except for representations and warranties
that speak as of a specific date, which representations and warranties must be
correct as of such date), all necessary consents and waivers of third parties
shall have been obtained and each party shall have performed and complied in all
material respects with the covenants and conditions required by this Agreement
to be performed or complied with by the party at or prior to the
Closing.

     

    (d)  The
KFLP shall have surrendered that certain $1,000,000 Secured Promissory Note
dated June 29, 2009 to the Company for cancellation in exchange for the issuance
by the Company of 4,000,000 shares of Company Common Stock to the KFLP and the
payment by the Company of any unpaid interest on such Secured Promissory
Note.

     

    ARTICLE
III

    REPRESENTATIONS
AND WARRANTIES

     

    Section
3.1.  Representations and
Warranties of the Company.  Except as set forth in the SEC
Reports or under the corresponding section of the Annex I Disclosure Schedules
delivered concurrently herewith, the Company makes the following representations
and warranties as of the date hereof to the Purchasers:

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

     

    (a)  Subsidiaries.  Except
for one direct Subsidiary in Mexico, ONIBIOTEC SAPI de C.V., the Company has no
direct or indirect Subsidiaries.

     

    (b)  Organization and
Qualification.  The Company is an entity duly incorporated or
otherwise organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or organization (as applicable), with the
requisite corporate power and authority to own and use its properties and assets
and to carry on its business as currently conducted.  The Company is
not in violation of any of the provisions of its certificate or articles of
incorporation, bylaws or other organizational or charter
documents.  The Company is duly qualified to conduct business and is
in good standing as a foreign corporation or other entity in each jurisdiction
in which the nature of the business conducted or property owned by it makes such
qualification necessary, except where the failure to be so qualified or in good
standing, as the case may be, would not have or reasonably be expected to result
in (i) a material adverse effect on the legality, validity or enforceability of
any Transaction Document, (ii) a material adverse effect on the results of
operations, assets, prospects, business or condition (financial or otherwise) of
the Company, taken as a whole, or (iii) adversely impair the Company’s ability
to perform fully on a timely basis its obligations under any Transaction
Document (any of (i), (ii) or (iii), a “Material Adverse
Effect”).

     

    (c)   Authorization;
Enforcement.  The Company has the requisite corporate power and
authority to enter into and to consummate the transactions contemplated by each
of the Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder.  The execution and delivery of each of the
Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all
necessary action on the part of the Company and no further consent or action is
required by the Company, its Board of Directors or its
stockholders.  Each Transaction Document has been (or upon delivery
will have been) duly executed by the Company and, when delivered in accordance
with the terms hereof, will constitute the valid and binding obligation of the
Company, enforceable against the Company in accordance with its terms, except
(i) as limited by general equitable principles and applicable bankruptcy,
insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors’ rights generally, (ii) as limited by laws
relating to the availability of specific performance, injunctive relief or other
equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.

     

    (d)   No
Conflicts.  The execution, delivery and performance of the
Transaction Documents by the Company and the consummation by the Company of the
transactions contemplated hereby and thereby do not and will not (i) conflict
with or violate any provision of the Company’s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii)
conflict with, or constitute a default (or an event that with notice or lapse of
time or both would become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation (with or without notice,
lapse of time or both) of, any agreement, credit facility, debt or other
instrument (evidencing a Company debt or otherwise) or other understanding to
which the Company is a party or by which any property or asset of the Company is
bound or affected, or (iii) result in a violation of any law, rule, regulation,
order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company is subject (including federal and
state securities laws and regulations), or by which any property or asset of the
Company is bound or affected; except in the case of each of clauses (ii) and
(iii), such as would not have or reasonably be expected to result in a Material
Adverse Effect.

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

     

    (e)  Filings, Consents and
Approvals.  The Company is not required to obtain any consent,
waiver, authorization or order of, give any notice to, or make any filing or
registration with, any court or other federal, state, local or other
governmental authority or other Person in connection with the execution,
delivery and performance by the Company of the Transaction Documents, other than
(a) any applicable Blue Sky filings, (b) such as have already been obtained or
such exemptive filings as are required to be made under applicable securities
laws, and (c) such other filings as may be required following the Closing Date
under the Securities Act, the Exchange Act and corporate law.

     

    (f)  Issuance of the
Securities.  The Shares are duly authorized and, the Shares,
when issued and paid for in accordance with the Transaction Documents, will be
duly and validly issued, fully paid and nonassessable, free and clear of all
Liens and shall not be subject to preemptive rights or similar rights of
stockholders.  The Company has reserved from its duly authorized
capital stock the number of Shares issuable pursuant to this
Agreement.

     

    (g)  Capitalization.  The
number of shares and type of all authorized, issued and outstanding capital
stock, options and other securities of the Company (whether or not presently
convertible into or exercisable or exchangeable for shares of capital stock of
the Company) is as set forth in the SEC Reports.  All outstanding
shares of capital stock are duly authorized, validly issued, fully paid and
nonassessable and have been issued in compliance with all applicable securities
laws.  Except as disclosed in the SEC Reports, there are no
outstanding options, warrants, script rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities, rights or
obligations convertible into or exercisable or exchangeable for, or giving any
Person any right to subscribe for or acquire, any shares of Common Stock, or
contracts, commitments, understandings or arrangements by which the Company is
or may become bound to issue additional shares of Common Stock, or securities or
rights convertible or exchangeable into shares of Common
Stock.  Except as set forth in the SEC Reports, there are no
anti-dilution or price adjustment provisions contained in any security issued by
the Company (or in any agreement providing rights to security holders) and the
issue and sale of the Company Securities will not obligate the Company to issue
shares of Common Stock or other securities to any Person (other than the
Purchaser) and will not result in a right of any holder of Company securities to
adjust the exercise, conversion, exchange or reset price under such
securities.

     

    (h)  SEC Reports; Financial
Statements.

     

    (i)           The
Company has filed all reports required to be filed by it under the Securities
Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) of the
Exchange Act, for the two years preceding the date hereof (or such shorter
period as the Company was required by law to file such material) (the foregoing
materials, including the exhibits thereto (together with any materials filed by
the Company under the Exchange Act, whether or not required), being collectively
referred to herein as the “SEC Reports” and,
together with this Agreement and (the “Disclosure
Materials”) on a timely basis or has received a valid extension of such
time of filing and has filed any such SEC Reports prior to the expiration of any
such extension.  True and complete copies of the SEC Reports are
available at www.sec.gov.

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

     

    (ii)          As
of their respective dates, the SEC Reports complied in all material respects
with the requirements of the Securities Act and the Exchange Act and the rules
and regulations of the Commission promulgated thereunder, as applicable, and
none of the SEC Reports, when filed, contained any untrue statement of a
material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading.

     

    (iii)         The
financial statements of the Company included in the SEC Reports comply in all
material respects with applicable accounting requirements and the rules and
regulations of the Commission with respect thereto as in effect at the time of
filing.  Such financial statements have been prepared in accordance
with generally accepted accounting principles applied on a consistent basis
during the periods involved (“GAAP”), except as may
be otherwise specified in such financial statements or the notes thereto and
except that unaudited financial statements may not contain all footnotes
required by GAAP or may be condensed or summary statements, and fairly present
in all material respects the financial position of the Company and its
consolidated subsidiaries as of and for the dates thereof and the results of
operations and cash flows for the periods then ended, subject, in the case of
unaudited statements, to normal, immaterial, year-end audit
adjustments.

     

    (iv)        All
material agreements to which the Company is a party or to which the property or
assets of the Company are subject are included as part of or specifically
identified in the SEC Reports.  Other than the material contracts
listed in the SEC Reports, as otherwise provided to the Purchaser, the Company
has no material contracts.  Except as set forth in the SEC Reports,
the Company is not in breach or violation of any material contract, which breach
or violation would have a Material Adverse Effect.

     

    (i)  Absence of Material
Changes.  Since the date of the latest audited financial
statements included within the SEC Reports, except as disclosed in the SEC
Reports, (i) there has been no event, occurrence or development that has had or
that could reasonably be expected to result in a Material Adverse Effect, (ii)
the Company has not incurred any liabilities (contingent or otherwise) other
than (A) trade payables and accrued expenses incurred in the ordinary course of
business consistent with past practice and (B) liabilities not required to be
reflected in the Company’s financial statements pursuant to GAAP or required to
be disclosed in filings made with the Commission, (iii) the Company has not
altered its method of accounting or the identity of its auditors, (iv) the
Company has not declared or made any dividend or distribution of cash or other
property to its stockholders or purchased, redeemed or made any agreements to
purchase or redeem any shares of its capital stock and (v) the Company has not
issued any equity securities to any officer, director or Affiliate, except
pursuant to existing Company stock option plans and agreements.

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    (j)  Litigation.  Except
as disclosed in the SEC Reports, there is no action, suit, inquiry, notice of
violation, proceeding or investigation pending or, to the knowledge of the
Company, threatened against or affecting the Company, or its properties before
or by any court, arbitrator, governmental or administrative agency or regulatory
authority (federal, state, county, local or foreign) (collectively, an “Action”) which (i)
adversely affects or challenges the legality, validity or enforceability of any
of the Transaction Documents or the Securities or (ii) could, if there were an
unfavorable decision, have or reasonably be expected to result in a Material
Adverse Effect.

     

    (k)  Labor
Relations.  The Company is not involved in any material union
labor dispute nor, to the knowledge of the Company, is any such dispute
threatened.  The Company believes that their relations with their
employees are good.  No executive officer (as defined in Rule 501(f)
of the Securities Act) has notified the Company that such officer intends to
leave the Company or otherwise terminate such officer’s employment with the
Company.  The Company is in compliance with all federal, state, local
and foreign laws and regulations respecting employment and employment practices,
terms and conditions of employment and wages and hours, except where failure to
be in compliance would not, either individually or in the aggregate, result in a
Material Adverse Effect.

     

    (l)  Compliance.  Except
as disclosed in the SEC Reports, the Company (i) is not in default under or in
violation of (and no event has occurred that has not been waived that, with
notice or lapse of time or both, would result in a default by the Company or any
Subsidiary under), nor has the Company received notice of a claim that it is in
default under or that it is in violation of, any indenture, loan or credit
agreement or any other agreement or instrument to which it is a party or by
which it or any of its properties is bound (whether or not such default or
violation has been waived), (ii) is not in violation of any order of any court,
arbitrator or governmental body, or (iii) is not or has been in violation of any
statute, rule or regulation of any governmental authority, including without
limitation all foreign, federal, state and local laws applicable to its
business, except in the case of clauses (i), (ii) and (iii) as would not have or
reasonably be expected to result in a Material Adverse Effect.

     

    (m)  Regulatory
Permits.  The Company possesses all certificates,
authorizations and permits issued by the appropriate federal, state, local or
foreign regulatory authorities necessary to conduct its current business as
described in the SEC Reports, except where the failure to possess such permits
would not have or reasonably be expected to result in a Material Adverse Effect
(“Material
Permits”), and the Company has not received any notice of proceedings
relating to the revocation or modification of any Material Permit.

     

    (n)  Title to
Assets.  The Company has good and marketable title in fee
simple to all real property owned by it and good and marketable title in all
personal property owned by it, in each case free and clear of all Liens, except
for Liens as do not materially affect the value of such property and do not
materially interfere with the use made and proposed to be made of such property
by the Company and Liens for the payment of federal, state or other taxes, the
payment of which is neither delinquent nor subject to penalties.  To
the knowledge of the Company, any real property and facilities held under lease
by the Company are held by it under valid, subsisting and enforceable leases
with which the Company is in material compliance.

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    (o)  Patents and
Trademarks.  The Company has, or has rights to use, all
patents, patent applications, trademarks, trademark applications, service marks,
trade names, copyrights, licenses and other similar rights that are necessary or
material for use in connection with their respective businesses as described in
the SEC Reports and which the failure to so have could have or reasonably be
expected to result in a Material Adverse Effect (collectively, the “Intellectual Property
Rights”).  Except as disclosed in its SEC Reports, the Company
has not received a written notice that the Intellectual Property Rights used by
the Company violates or infringes the rights of any Person.  To the
knowledge of the Company, all such Intellectual Property Rights are enforceable
and there is no existing infringement by another Person of any of the
Intellectual Property Rights.

     

    (p)  Insurance.  The
Company is insured by insurers of recognized financial responsibility against
such losses and risks and in such amounts as are prudent and customary in the
businesses in which the Company is engaged.  The Company has no reason
to believe that it will not be able to renew its existing insurance coverage as
and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business.

     

    (q)  Transactions with Affiliates
and Employees.  Except as set forth in the SEC Reports, none of
the officers or directors of the Company and, to the knowledge of the Company,
none of the employees of the Company is presently a party to any transaction
with the Company (other than for services as employees, officers and directors),
including any contract, agreement or other arrangement providing for the
furnishing of services to or by, providing for rental of real or personal
property to or from, or otherwise requiring payments to or from any officer,
director or such employee or, to the knowledge of the Company, any entity in
which any officer, director, or any such employee has a substantial interest or
is an officer, director, trustee or partner.

     

    (r)  Certain
Fees.  No brokerage or finder’s fees or commissions are or will
be payable by the Company to any broker, financial advisor or consultant,
finder, placement agent, investment banker, bank or other Person with respect to
the transactions contemplated by this Agreement, the Company has not taken any
action that would cause any of the Purchasers to be liable for any such fees or
commissions and the Company agrees to indemnify the Purchasers for any such fees
or commissions.

     

    (s)  Private
Placement.  Assuming the accuracy of each Purchaser’s
representations and warranties set forth in Section 3.2 and assuming no unlawful
distribution of the Securities by the Purchaser, no registration under the
Securities Act is required for the offer and sale of the Securities by the
Company to the Purchaser as contemplated hereby.  The issuance and
sale of the Securities hereunder does not contravene the rules and regulations
of the OTC-BB.  Neither the Company nor any Person acting on the
Company’s behalf has sold or offered to sell or solicited any offer to buy the
Securities by means of any form of general solicitation or
advertising.  The Company has offered the Shares for sale only to such
Persons it believes to be an accredited investor.

     

    (t)  Registration
Rights.  Except as described in the SEC Reports, no Person has
any right to cause the Company to effect the registration under the Securities
Act of any securities of the Company.

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

     

    (u)  Exchange
Act.  The Company’s Common Stock is registered pursuant to
Section 12(g) of the Exchange Act and trades on the OTC-BB.

     

    (v)  Disclosure.  All
disclosure provided to the Purchaser regarding the Company, its business and the
transactions contemplated hereby, including the Disclosure Schedules to this
Agreement, furnished by or on behalf of the Company are true and correct and do
not contain any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements made therein, in the
light of the circumstances under which they were made, not
misleading.  No event or circumstance has occurred or information
exists with respect to the Company or its business, properties, prospects,
operations or condition (financial or otherwise), which, under applicable law,
rule or regulation, requires public disclosure or announcement by the Company
but which has not been so publicly announced or disclosed.

     

    (w)  Taxes.  Except
for matters that would not, individually or in the aggregate, have or reasonably
be expected to result in a Material Adverse Effect, the Company has filed all
necessary federal, state and foreign income and franchise tax returns and has
paid or accrued all taxes shown as due thereon, and the Company has no knowledge
of a tax deficiency which has been asserted or threatened against the
Company.

     

    Purchaser
acknowledges and agrees that the Company does not make or has not made any
representations or warranties with respect to the transactions contemplated
hereby other than those specifically set forth in this Section 3.1.

     

    Section
3.2    Representations and
Warranties of the Purchasers.  Each Purchaser severally and not
jointly represents and warrants as of the date hereof to the Company as
follows:

     

    (a)  Organization;
Authority.  The Purchaser is either a person or an entity duly
organized, validly existing and in good standing under the laws of the
jurisdiction of its organization with full right, corporate or partnership power
and authority to enter into and to consummate the transactions contemplated by
the Transaction Documents and otherwise to carry out its obligations
thereunder.  The execution, delivery and performance by such Purchaser
of the transactions contemplated by this Agreement have been duly authorized by
all necessary corporate or similar action on the part of such
Purchaser.  Each Transaction Document to which it is a party has been
duly executed by such Purchaser, and when delivered by such Purchaser in
accordance with the terms hereof, will constitute the valid and legally binding
obligation of such Purchaser, enforceable against it in accordance with its
terms, except (i) as limited by general equitable principles and applicable
bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors’ rights generally, (ii) as
limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies and (iii) insofar as indemnification and
contribution provisions may be limited by applicable law.

     

    (b)  Purchase for Own
Account.  The Purchaser is acquiring the Shares as principal
for its own account and not with a view to or for distributing or reselling such
Shares or any part thereof, without prejudice, however, to Purchaser’s right,
subject to the provisions of this Agreement, at all times to sell or otherwise
dispose of all or any part of such Shares pursuant to an effective registration
statement under the Securities Act or under an exemption from such registration
and in compliance with applicable federal and state securities
laws.  The Purchaser is acquiring the Shares hereunder in the ordinary
course of its business.  Purchaser does not have any agreement or
understanding, directly or indirectly, with any Person to distribute any of the
Shares.

     

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

     

    (c)  Purchaser
Status.  At the time the Purchaser was offered the Shares, it
was, and at the date hereof it is an “accredited investor” as defined in Rule
501(a) under the Securities Act.  The Purchaser is not required to be
registered as a broker-dealer under Section 15 of the Exchange Act.

     

    (d)  Experience of
Purchaser.  The Purchaser has such knowledge, sophistication
and experience in business and financial matters so as to be capable of
evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment.  The
Purchaser is able to bear the economic risk of an investment in the Securities
and, at the present time, is able to afford a complete loss of such
investment.

     

    (e)  Reliance on
Exemptions.  The Purchaser understands that the Securities are
being offered and sold to it in reliance upon specific exemptions from the
registration requirements of United States federal and state securities laws and
that the Company is relying upon the truth and accuracy of, and the Purchaser’s
compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Purchaser set forth herein in order to determine the
availability of such exemptions and the eligibility of the Purchaser to acquire
the Securities.

     

    (f)  Information.  The
Purchaser and its advisors, if any, have had access to all materials relating to
the business, finances and operations of the Company including, without
limitation, the Company’s most recent SEC Reports, that have been requested by
the Purchaser or its advisors, if any.  The Purchaser has been
afforded the opportunity to ask questions of the Company and receive answers
from the Company.  The Purchaser has requested, received and
considered all information it deems relevant to make an informed decision to
purchase the Securities.  The Purchaser acknowledges and understands
that its investment in the Securities involves a significant degree of
risk.

     

    (g)  Governmental
Review.  The Purchaser understands that no United States
federal or state agency or any other government or governmental agency has
passed upon or made any recommendation or endorsement of the Securities or an
investment therein.

     

    (h)  Residency.  The
Purchaser is a resident of (or, if an entity, has its principal place of
business in) the jurisdiction set forth by the Purchaser’s name on the signature
of this Agreement.

     

    (i)  Certain
Fees.  No brokerage or finder’s fees or commissions are or will
be payable by the Purchaser to any broker, financial advisor or consultant,
finder, placement agent, investment banker, bank or other Person with respect to
the transactions contemplated by this Agreement, the Purchaser has not taken any
action that would cause the Company or any other Purchaser to be liable for any
such fees or commissions and each Purchaser agrees to indemnify the Company and
each other Purchaser for any such fees or commissions.

     

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

     

    (j)  
Short
Sales.  The Purchaser has not directly or indirectly, nor has
any Person acting on behalf of or pursuant to any understanding with such
Purchaser, executed any Short Sales or granted any option for the purchase of or
entered into any hedging or similar transaction with the same economic effect as
a Short Sale, in the securities of the Company since the time period beginning
two weeks prior to the time that such Purchaser was first contacted regarding an
investment in the Company (“Discussion Time”)
through the date hereof.  During such period, neither Purchaser nor
any Person acting on behalf of or pursuant to any understanding with Purchaser,
has taken, directly or indirectly, any actions to trade in the Company’s
Securities that might reasonably be expected to cause or result, under the
Securities Act or Exchange Act, or otherwise, or that has constituted,
stabilization or manipulation of the price of the Common
Stock.  Additionally, Purchaser is familiar with and agrees to comply
with Regulation M under the Exchange Act.

     

    (k)  No General
Solicitation.  The Purchaser is not purchasing the Securities
as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or other media or
broadcast over television or radio or presented at any seminar or any other
general solicitation or advertisement.

     

    (l)  
Confidentiality.  Other
than to other Persons party to this Agreement, the Purchaser has maintained the
confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this
transaction).

     

    (m) Acknowledgement of
Communication by the Company of 3 Day Voidability
Privilege.  The Purchaser acknowledges and understands that
Section 517.061 (11)(a)5 of the Florida Statutes provides that "When sales are
made to five or more persons in this state, any sale in this state made pursuant
to this subsection is voidable by the purchaser in such sale either within 3
days after the first tender of consideration is made by such purchaser to the
issuer, an agent of the issuer, or an escrow agent or within 3 days after the
availability of that privilege is communicated to such purchaser, whichever
occurs later” and that this Section 3.2(m) is intended to constitute the
required communication under Section 517.061(11)(a)5 of the Florida
Statutes.

     

    The
Company acknowledges and agrees that the Purchasers do not make or has not made
any representations or warranties with respect to the transactions contemplated
hereby other than those specifically set forth in this Section 3.2.

     

    ARTICLE
IV

    OTHER
AGREEMENTS OF THE PARTIES

     

     Section
4.1.  Use of
Proceeds. The Company covenants and agrees that $1,000,000 of the
proceeds received under this Agreement shall be reserved for and allocated
solely to the expenses incurred in the further development of the Company's
DPOLT synthetic chemistry platform, essential to the production of its lead
antibiotic, MU 1140, subject to the goals set forth by the two year NSF SBIR
Phase II grant the Company received on February 15, 2008.  The
remaining proceeds received under this Agreement shall be used as the Company’s
management and the Board of Directors shall determine in their sole
discretion.

     

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

     

    Section
4.2      Transfer
Restrictions.

     

    (a)  The
Securities may only be disposed of pursuant to an effective registration
statement under the Securities Act or pursuant to an available exemption from
the registration requirements of the Securities Act, and in compliance with any
applicable state securities laws. The Securities shall contain a restrictive
legend in the following form:

     

    THESE
SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT.

     

    (b)  Each
Purchaser agrees that the removal of the restrictive legend from certificates
representing Securities as set forth in this Section 4.2 is expressly predicated
upon the Purchaser’s covenant and agreement in this Section 4.2(b) that the
Purchaser shall in all cases sell or otherwise transfer the Securities pursuant
to:  (i) an effective registration statement under the Securities Act,
in full compliance with all prospectus delivery requirements under the
Securities Act and in accordance with the plan of distribution described in the
prospectus delivered by Purchaser, or (ii) an available exemption from
registration under the Securities Act.

     

    Section
4.3     Furnishing of
Information.

     

    (a)  
For such period as the Purchaser continues to own the Shares, the Company
covenants to use its reasonable efforts to timely file (or obtain extensions in
respect thereof and file within the applicable grace period) all reports
required to be filed by the Company after the date hereof pursuant to the
Exchange Act.  In addition, the Company shall use its reasonable
efforts to take all actions necessary to meet the “registrant eligibility”
requirements set forth in the general instructions to Form S-3 or any successor
form thereto, to continue to be eligible to register the resale of its Common
Stock on a registration statement on Form S-3 under the Securities
Act.

     

    (b)  
For such period as the Purchaser continues to own the Shares, if the Company is
not required to file reports pursuant to the Exchange Act, it will prepare and
furnish to the Purchaser and make publicly available in accordance with Rule 144
such information as is required for the Purchaser to sell the Securities under
Rule 144 and the Company further covenants that it will take such further action
as any holder of Securities may reasonably request, all to the extent required
from time to time to enable such Person to sell such Securities without
registration under the Securities Act within the limitation of the exemptions
provided by Rule 144.

     

    
      
         

      

      
        12

        
          

        

      

      
         

      

    

     

    (c)  For
such period as the Purchaser continues to own the Shares, the Company shall
ensure that each of the following reports are available at www.sec.gov: 
(i) within ten days after the filing thereof with the SEC, a copy of its Annual
Report on Form 10-K, its Quarterly Reports on Form 10-Q, its proxy statements
and any Current Reports on Form 8-K; and (ii) within one day after release,
copies of all press releases issued by the Company or any of its
Subsidiaries.

     

    Section
4.4 Trading Market of
Common Stock.  The Company hereby agrees to use its reasonable
efforts to maintain the eligibility for trading of the Common Stock on the
Trading Market.  The Company further agrees, if the Company applies to
have the Common Stock traded on any other trading market, it will include in
such application the Shares, and will take such other action as is necessary or
desirable in the opinion of the Purchaser to cause the Shares to be listed on
such other trading market as promptly as possible.  The Company will
take all action reasonably necessary to continue the listing and trading of its
Common Stock on a trading market and will comply in all respects with the
Company’s reporting, filing and other obligations under the bylaws or rules of
the trading market.

     

    Section
4.5  Sales
by Purchasers. Each Purchaser covenants to sell any Securities sold by it
in compliance with applicable prospectus delivery requirements, if any, or
otherwise in compliance with the requirements for an exemption from registration
under the Securities Act.  Each Purchaser will not make any sale,
transfer or other disposition of the Securities in violation of federal or state
securities laws.

     

    ARTICLE
V

    MISCELLANEOUS

     

    Section
5.1.  Entire
Agreement.  The Transaction Documents, together with the
exhibits and schedules thereto, contain the entire understanding of the parties
with respect to the Securities and supersede all prior agreements and
understandings, oral or written, with respect to such matters, which the parties
acknowledge have been merged into such documents, exhibits and
schedules.

     

    Section
5.2.  Amendments;
Waivers.  No provision of this Agreement may be waived or
amended except in a written instrument signed, in the case of an amendment, by
the Company and the Purchaser or, in the case of a waiver, by the party against
whom enforcement of any such waiver is sought.  No waiver of any
default with respect to any provision, condition or requirement of this
Agreement shall be deemed to be a continuing waiver in the future or a waiver of
any subsequent default or a waiver of any other provision, condition or
requirement hereof, nor shall any delay or omission of either party to exercise
any right hereunder in any manner impair the exercise of any such
right.

     

    
      
         

      

      
        13

        
          

        

      

      
         

      

    

    Section
5.3.  Successors and
Assigns.  This Agreement shall be binding upon and inure to the
benefit of the parties and their successors and permitted
assigns.  The Company may not assign this Agreement or any rights or
obligations hereunder without the prior written consent of the Purchaser;
provided, however, that no consent shall be required in connection with a
merger, consolidation or sale of substantially all of the Company’s
assets.  Any Purchaser may assign any or all of its rights under this
Agreement to any Person in connection with the transfer of the Securities,
provided such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions hereof that apply to the
“Purchaser”.

     

    Section
5.4.  No
Third-Party Beneficiaries.  This Agreement is intended for the
benefit of the parties hereto and their respective successors and permitted
assigns and is not for the benefit of, nor may any provision hereof be enforced
by, any other Person.

     

    Section
5.5.  Governing
Law.  All questions concerning the construction, validity,
enforcement and interpretation of the Transaction Documents shall be governed by
and construed and enforced in accordance with the internal laws of the State of
Florida, without regard to the principles of conflicts of law
thereof.  Each party agrees that all legal proceedings concerning the
interpretations, enforcement and defense of the transactions contemplated by
this Agreement and any other Transaction Documents (whether brought against a
party hereto or its respective affiliates, directors, officers, shareholders,
employees or agents) shall be commenced exclusively in the United States federal
courts and the state courts located in the County of Hillsborough, State of
Florida.  Each party hereto hereby irrevocably submits to the
exclusive jurisdiction of the state and federal courts sitting in the County of
Hillsborough, State of Florida for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed
herein (including with respect to the enforcement of any of the Transaction
Documents), and hereby irrevocably waives, and agrees not to assert in any suit,
action or proceeding, any claim that it is not personally subject to the
jurisdiction of any such court, that such suit, action or proceeding is
improper.  Each party hereto hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action
or proceeding by delivering a copy thereof via overnight delivery (with evidence
of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof.  Nothing contained herein shall
be deemed to limit in any way any right to serve process in any manner permitted
by law.  Each party hereto (including its affiliates, agents,
officers, directors and employees) hereby irrevocably waives, to the fullest
extent permitted by applicable law, any and all right to trial by jury in any
legal proceeding arising out of or relating to this Agreement or the
transactions contemplated hereby.  If either party shall commence an
action or proceeding to enforce any provisions of a Transaction Document, then
the prevailing party in such action or proceeding shall be reimbursed by the
other party for its attorneys’ fees and other costs and expenses incurred with
the investigation, preparation and prosecution of such action or
proceeding.

     

    Section
5.6.  Execution.  This
Agreement may be executed in two or more counterparts, all of which when taken
together shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the
other party, it being understood that both parties need not sign the same
counterpart.  In the event that any signature is delivered by
facsimile or other electronic transmission, such signature shall create a valid
and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and affect as if such facsimile or other
electronically transmitted signature page were an original thereof.

     

    
      
         

      

      
        14

        
          

        

      

      
         

      

    

     

    Section
5.7.  Severability.  If
any provision of this Agreement is held to be invalid or unenforceable in any
respect, the validity and enforceability of the remaining terms and provisions
of this Agreement shall not in any way be affected or impaired thereby and the
parties will attempt to agree upon a valid and enforceable provision that is a
reasonable substitute therefor, and upon so agreeing, shall incorporate such
substitute provision in this Agreement.

     

    Section
5.8.  Construction.  The
headings herein are for convenience only, do not constitute a part of this
Agreement and shall not be deemed to limit or affect any of the provisions
hereof.  The parties agree that each of them and/or their respective
counsel has reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any
ambiguities are to be resolved against the drafting party shall not be employed
in the interpretation of the Transaction Documents or any amendments
hereto.

     

    Section
5.9.  Legal
Counsel. The Company and KFLP acknowledge that the law firm Shumaker,
Loop & Kendrick, LLP ("Shumaker") currently represents the Company and KFLP
on unrelated matters.  The Company and KFLP hereby waive any potential
conflict of interest arising from the representation by Shumaker and
consents to the continued representation by Shumaker of the Company in
connection with the matters covered by this Agreement.  The KFLP further
acknowledges and represents that it has had an opportunity to retain its own
separate legal counsel to represent it in this matter.

     

    Section
5.10.  Notice of Three-Day Right of
Rescission. PURSUANT TO
SECTION 517.061(11)(a)5 OF THE FLORIDA STATUTES, PURCHASERS HAVE A THREE-DAY
RIGHT OF RESCISSION. IF A PURCHASER HAS EXECUTED THIS AGREEMENT AND TENDERED THE
PURCHASE PRICE FOR THE PURCHASE OF SHARES, THE PURCHASER MAY ELECT, WITHIN THREE
BUSINESS DAYS AFTER SIGNING THIS AGREEMENT OR BEING FIRST NOTIFIED OF THIS
RIGHT, WHICHEVER IS LATER, TO WITHDRAW FROM THIS AGREEMENT AND RECEIVE A FULL
REFUND AND RETURN (WITHOUT INTEREST) OF ANY MONEY PAID BY PURCHASER. A
PURCHASER'S WITHDRAWAL WILL BE WITHOUT ANY FURTHER LIABILITY TO ANY PERSON. TO
ACCOMPLISH SUCH WITHDRAWAL, A PURCHASER NEED ONLY SEND A LETTER OR E-MAIL
TO THE COMPANY AT 3000 BAYPORT DRIVE, SUITE 685, TAMPA, FLORIDA ATTN: DAVID B.
HIRSCH, PRESIDENT AND CHIEF EXECUTIVE OFFICER (dhirsh@oragenics.com), INDICATING
THE INTENTION TO WITHDRAW. SUCH LETTER OR E-MAIL MUST BE SENT AND POSTMARKED
PRIOR TO THE END OF THE AFOREMENTIONED THIRD BUSINESS DAY. IF A
PURCHASER SENDS A LETTER, IT IS PRUDENT TO SEND IT BY CERTIFIED MAIL,
RETURN RECEIPT REQUESTED, TO ENSURE THAT IT IS RECEIVED AND ALSO TO EVIDENCE THE
TIME AND DATE WHEN IT IS MAILED. SHOULD A PURCHASER MAKE THIS REQUEST ORALLY,
SUCH PURCHASER SHOULD ASK FOR WRITTEN CONFIRMATION THAT HIS REQUEST HAS BEEN
RECEIVED. THE FOREGOING IS INTENDED TO CONSTITUTE THE NOTICE REQUIRED UNDER THE
FLORIDA STATUTES. ACCORDINGLY, EACH  PURCHASER WILL HAVE THREE DAYS AFTER
THE FIRST TENDER OF THE PURCHASE PRICE IS MADE BY SUCH PURCHASER TO VOID
THEIR PURCHASE OF THESE SECURITIES.

     

    
      
         

      

      
        15

        
          

        

      

      
         

      

    

     

     [REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK

     

    AND
SIGNATURE PAGES FOLLOW]

     

    
      
         

      

      
        16

        
          

        

      

      
         

      

    

    IN WITNESS WHEREOF, the
parties hereto have caused this Common Stock Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first
indicated above.

     

    COMPANY

    

    ORAGENICS,
INC.

     

    
      
        	
                By:

              	
                /s/ David Hirsch

              	 
      
	 
      	 
      
	
                David
      Hirsch, President and Chief Executive Officer

              	 
      

      

    

     

    PURCHASERS

    

    
      
        	
                /s/Carol E. Martin

              	 
      
	
                Carol
      E. Martin

              	 
      

      

    

    

    Investment
Amount: $1,000,000 for 4,000,000 shares of
common stock

    Address:

    P.O. Box
1291

    Tarpon Springs, FL
34688

    

    THE
KOSKI FAMILY LIMITED PARTNERSHIP

    

    
      
        	
                By:

              	
                /s/ Christine L. Koski

              	 
      
	 
      	
                Christine
      L. Koski, Managing General Partner

              	 
      

      

    

    

    Investment
Amount: $1,500,000 for 6,000,000 shares of
common stock

    Address:

    3525
Turtle Creek Boulevard, Unit 19-B

    Dallas,
Texas 75219

    

    
      	
              /s/ Jeffrey D. Hillman

            	 
      
	
              Jeffrey
      D. Hillman

            	 
      

    

    

    Investment
Amount:  $54,062.50 for
216,250 shares of common
stock

    

    Paid
pursuant to cancellation of the same dollar amount of outstanding preferred
compensation obligations owed by the Company.

    /s/DH

    /s/JH

    

    [signature
pages to Common Stock Purchase Agreement]

    
      
         

      

      
        17

        
          

        

      

      
         

      

    

    

    Address: 6424 SW 26th Place

                    Gainesville, FL
32608

    

    
      
        	
                /s/Kelly H. Leaird

              	 
      
	
                Kelly
      H. Leaird

              	 
      

      

    

    

    Investment
Amount: $100,000.00
for 400,000
shares of common stock

    Address: 4969 SW 2nd Ct.

                     Ocala, FL
34471

    

    
      
        	
                /s/Mark Bailey

              	 
      
	
                Mark
      Bailey

              	 
      

      

    

    

    Investment
Amount: $100,000.00 for 400,000 shares of
common stock

    Address:

    1200 Plantation Drive. Suite
210

    St. Augustine, FL
32080

    

    
      
        	
                /s/Kris A. Persinger

              	 
      
	
                Kris
      A. Persinger

              	 
      

      

    

    

    Investment
Amount: $50,000
for 200,000
shares of common stock

    Address:

    4360 Van Ness St.
NW

    Washington, DC
20016

    

    
      
        	
                /s/First Clearing, LLC C/F Roth IRA FBO Kris A.
      Persinger

              	 
      
	
                First
      Clearing, LLC C/F Roth IRA FBO Kris A. Persinger

              	 
      

      

    

    

    Investment
Amount: $50,000
for 200,000
shares of common stock

    Address:

    P.O. Box
66701

    St. Louis, MO
63166

    

    
      	
              /s/Richard Dresden

            	 
      
	
              Richard
      Dresden

            	 
      

    

    

    Investment
Amount: $75,000
for 300,000
shares of common stock

    Address:

    1511 W.
Superior

    Chicago, IL
60642

    
      
         

      

      
        18

        
          

        

      

      
         

      

    

    

    
      
        	
                /s/John Diana

              	 
      
	
                John
      Diana

              	 
      

      

    

    

    Investment
Amount: $50,000
for 200,000
shares of common stock

    Address:

    1101 Castle Oaks
Drive

    Napa, CA
94558

    

    
      
        	
                /s/Michael Wells

              	 
      
	
                Michael
      Wells

              	 
      

      

    

    

    Investment
Amount: $25,000
for 100,000
shares of common stock

    Address:

    3636 Woodridge
Pl.

    Pam Harbor, FL
34684

    

    [signature
pages to Common Stock Purchase Agreement]

     

    
      
         

      

      
        19Unassociated Document

    NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”), AND, ACCORDINGLY, MAY
NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION
OF COUNSEL TO THE TRANSFEROR REASONABLY ACCEPTABLE TO THE COMPANY TO SUCH
EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
COMPANY.

     

    WARRANT

     

    To
Purchase __________ Shares of Preferred Stock Series G of

     

    GEOS
COMMUNICATIONS, INC.

     

    THIS WARRANT (the “Warrant”) certifies that, for
value received, ______________ (the “Holder”), is entitled, upon
the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after March 5, 2010 (the “Initial Exercise Date”) and on
or prior to the three-year anniversary of the Initial Exercise Date (the “Termination Date”), but not
thereafter, to subscribe for and purchase from Geos Communications, Inc., a
Washington corporation (the “Company”), up to _________
shares (the “Warrant
Shares”) of Preferred Stock Series G, no par value per share, of the
Company (the “Series G
Preferred Shares”).  The purchase price of each Series G
Preferred Share (the “Exercise
Price”) under this Warrant shall be $0.50, subject to adjustment
hereunder.

     

    1. Title to
Warrant.  Prior to the Termination Date and subject to
compliance with applicable laws and Section 7 of this Warrant, this Warrant and
all rights hereunder are transferable, in whole or in part, at the office or
agency of the Company by the Holder in person or by duly authorized attorney,
upon surrender of this Warrant together with the Assignment Form attached hereto
as Exhibit A
(the “Assignment Form”),
properly endorsed.

     

    2. Authorization of
Shares.  The Company covenants that all Warrant Shares which
may be issued upon the exercise of the purchase rights represented by this
Warrant will, upon exercise of the purchase rights represented by this Warrant,
be duly authorized, validly issued, fully paid and nonassessable and free from
all taxes, liens and charges in respect of the issue thereof (other than taxes
in respect of any transfer occurring contemporaneously with such
issue).

     

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

    

    3. Exercise of
Warrant.

     

    (a) Exercise
of the purchase rights represented by this Warrant may be made at any time or
times on or after the Initial Exercise Date and on or before the Termination
Date by delivery to the Company (or such other office or agency of the Company
as it may designate by notice in writing to the registered Holder at the address
of such Holder appearing on the books of the Company) of a duly executed
facsimile copy of the Notice of Exercise in the form attached hereto as Exhibit B (the “Notice of Exercise”); provided, however, within three
(3) Business Days of the date said Notice of Exercise is delivered to the
Company, the Holder shall have surrendered this Warrant to the Company, and, if
the Holder has not elected to make a cashless exercise as provided below, the
Company shall have received payment of the aggregate Exercise Price of the
shares thereby purchased by wire transfer or cashier’s check drawn on a United
States bank.  Certificates for Warrant Shares purchased hereunder
shall be delivered to the Holder no later than three (3) Business Days after the
delivery to the Company of the Notice of Exercise, surrender of this Warrant
and, if the Holder has not elected to make a cashless exercise as provided
below, payment of the aggregate Exercise Price as set forth above (“Warrant Share Delivery
Date”).  Prior to the issuance of such Warrant Shares, if the
Company fails to deliver to the Holder a certificate or certificates
representing the Warrant Shares pursuant to this Section 3(a) by the Warrant
Share Delivery Date, then the Holder will have the right to rescind such
exercise.  Nothing herein shall limit a Holder’s right to pursue any
other remedies available to it hereunder, at law or in equity, including,
without limitation, a decree of specific performance and/or injunctive relief
with respect to the Company’s failure to timely deliver certificates
representing Warrant Shares as required pursuant to the terms hereof. “Business Day” shall mean any
day other than: (i) Saturday or Sunday or (ii) a legal holiday on which banks in
the State of Texas are authorized to be closed for business.

     

    (b) If this
Warrant shall have been exercised in part, then the Company shall, at the time
of delivery of the certificate or certificates representing the Warrant Shares,
deliver to Holder a new Warrant evidencing the rights of Holder to purchase the
unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.

     

    (c) In the
event that the Holder elects to make a cashless exercise as provided above, the
Company shall issue to the Holder the number of Series G Preferred Shares equal
to the result obtained by (i) subtracting B from A, (ii) multiplying
the difference by C, and (iii) dividing the product by A, as set forth in
the following equation:

     

    
      	
               
      

            	
              X

            	
              =

            	
              (A - B) x
      C  where:

            
	 	 	 	       
      A

    

    
    

     

    
      	
               
      

            	
              X

            	
              =

            	
              the
      number of Series G Preferred Shares issuable upon a cashless exercise of
      the Warrant pursuant to the provisions of this
    Section 3.

            

    

     

    
      	
               
      

            	
              A

            	
              =

            	
              the
      Fair Market Value (as defined below) of one Series G Preferred Share on
      the date of net issuance exercise.

            

    

     

    
      	
               
      

            	
              B

            	
              =

            	
              the
      Exercise Price for one Series G Preferred Share under this
      Warrant.

            

    

     

    
      	
               
      

            	
              C

            	
              =

            	
              the
      number of Series G Preferred Shares as to which this Warrant is
      exercisable.

            

    

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    If the
foregoing calculation results in a negative number, then no Series G Preferred
Shares shall be issued upon a cashless exercise.

     

    For the
purpose of such calculations, the fair market value per share of the Series G
Preferred Shares shall be (i) if there is a public market for the Company’s
Common Stock, the dollar volume-weighted average price for the Company’s Common
Stock on the Over-The-Counter Bulletin Board, AMEX, NYSE, the NASDAQ National
Market or The NASDAQ SmallCap Market Principal Market during the period
beginning at 9:30:01 a.m., New York City Time, and ending at 4:00:00 p.m., New
York City Time, as reported by Bloomberg through its “Volume at Price” function
or, if the foregoing does not apply, the dollar volume-weighted average price of
such security in the over-the-counter market on the electronic bulletin board
for such security during the period beginning at 9:30:01 a.m., New York City
Time, and ending at 4:00:00 p.m., New York City Time, as reported by Bloomberg,
or, if no dollar volume-weighted average price is reported for such security by
Bloomberg for such hours, the average of the highest closing bid price and the
lowest closing ask price of any of the market makers for such security as
reported in the “pink sheets” by Pink Sheets LLC (formerly the National
Quotation Bureau, Inc.) for the twenty (20) trading days prior to the date of
determination of fair market value; or (ii) if there is no public market for the
Company’s Common Stock, determined by the Company’s Board of Directors in good
faith.

     

    4. No Fractional Shares or
Scrip.  No fractional shares or scrip representing fractional
shares shall be issued upon the exercise of this Warrant.  As to any
fraction of a share which Holder would otherwise be entitled to purchase upon
such exercise, the Company shall round such fraction of a share up to the
nearest whole share.

     

    5. Charges, Taxes and
Expenses.  Issuance of certificates for Warrant Shares shall be
made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such certificate, all of which
taxes and expenses shall be paid by the Company, and such certificates shall be
issued in the name of the Holder or in such name or names as may be directed by
the Holder; provided, however, that in the
event certificates for Warrant Shares are to be issued in a name other than the
name of the Holder, this Warrant when surrendered for exercise shall be
accompanied by the Assignment Form duly executed by the Holder, and the Company
may require, as a condition thereto, the payment of a sum sufficient to
reimburse it for any transfer tax incidental thereto.

     

    6. Closing of
Books.  The Company will not close its shareholder books or
records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.

     

    7. Transfer, Division and
Combination.

     

    (a) Subject
to compliance with any applicable securities laws and with the provisions of
Sections 1, 4 and 7(e) hereof, this Warrant and all rights hereunder are
transferable, in whole or in part, upon surrender of this Warrant at the
principal office of the Company, together with an Assignment Form completed and
duly executed by the Holder or its agent or attorney and funds sufficient to pay
any transfer taxes payable upon the making of such transfer.  Upon
such surrender and, if required, such payment, the Company shall execute and
deliver a new Warrant or Warrants in the name of the assignee or assignees and
in the denomination or denominations specified in the Assignment Form, and shall
issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled.  A Warrant,
if properly assigned, may be exercised by a new holder for the purchase of
Warrant Shares without having a new Warrant issued.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    (b) This
Warrant may be divided or combined with other Warrants upon presentation hereof
at the aforesaid office of the Company, together with a written notice
specifying the names and denominations in which new Warrants are to be issued,
signed by the Holder or its agent or attorney.  Subject to compliance
with Section 7(a), as to any transfer which may be involved in such division or
combination, the Company shall execute and deliver a new Warrant or Warrants in
exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice.

     

    (c) The
Company shall prepare, issue and deliver at its own expense (other than transfer
taxes) the new Warrant or Warrants under this Section 7.

     

    (d) The
Company agrees to maintain, at its aforesaid office, books for the registration
and the registration of transfer of the Warrants.

     

    (e) If, at
the time of the surrender of this Warrant in connection with any transfer of
this Warrant, the transfer of this Warrant shall not be registered pursuant to
an effective registration statement under the 1933 Act and under applicable
state securities or blue sky laws, the Company may require, as a condition of
allowing such transfer:  (i) that the Holder or assignee of this
Warrant, as the case may be, furnish to the Company a written opinion of counsel
(which opinion shall be in form, substance and scope customary for opinions of
counsel in comparable transactions) to the effect that such transfer may be made
without registration under the 1933 Act and under applicable state securities or
blue sky laws; (ii) that the Holder or assignee execute and deliver to the
Company an investment representation letter in form and substance reasonably
satisfactory to the Company; and (iii) that the assignee be an “accredited
investor” as defined in Rule 501(a) promulgated under the 1933 Act or a
qualified institutional buyer as defined in Rule 144A(a) under the 1933
Act.

     

    8. Representations of
Holder

     

    (a) Acquisition of Warrant for
Personal Account. The Holder represents and warrants that it is acquiring
the Warrant and Warrant Shares solely for its account for investment and not
with a present view toward public sale or distribution of said Warrant or
Warrant Shares or any part thereof and has no intention of selling or
distributing said Warrant Shares or any arrangement or understanding with any
other  person or entity regarding the sale or distribution of said
Warrant except as would not result in a violation of the 1933 Act.

     

    (b) Securities Are Not
Registered.

     

    (i) The
Holder understands that the offer and sale of the Warrant and the Warrant Shares
have not been exercised under the 1933 Act on the basis of specific exemptions
from the registration provisions of the 1933 Act, which exemptions depend upon,
among other things, the bona fide nature of the Holder’s investment intent as
expressed herein. The Holder realizes that the basis for such exemptions may not
be present if, notwithstanding its representations, the Holder has a present
intention of acquiring the securities for a fixed or determinable period in the
future, selling (in connection with a distribution or otherwise), granting any
participation in, or otherwise distributing the securities. The Holder has no
such present intention.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    (ii) The
Holder recognizes that the Warrant and the Warrant Shares must be held
indefinitely unless they are subsequently registered under the 1933 Act or an
exemption from such registration is available. The Holder recognizes that the
Company has no obligation to register the Warrant or, except as provided in the
Agreement and Plan of Merger dated as of February 12, 2010 by and among the
Company and the original Holder of this Warrant, the Warrant Shares, or to
comply with any exemption from such registration.

     

    (c) The
Holder understands and agrees that all certificates evidencing the Warrant
Shares to be issued to the Holder may bear a legend in substantially the
following form:

     

    THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED WITH THE
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE OF
THE UNITED STATES IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”), OR REGULATION S THEREUNDER,
AND ACCORDINGLY, MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED,
TRANSFERRED OR ASSIGNED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
FOR THE SECURITIES UNDER THE 1933 ACT OR PURSUANT TO AN AVAILABLE EXPEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
1933 ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAW AS EVIDENCED BY
A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF
WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.

     

    9. No Rights as Shareholder
until Exercise.  This Warrant does not entitle the Holder to
any voting rights or other rights as a shareholder of the Company prior to the
exercise hereof.  Upon the surrender of this Warrant, the delivery of
the Notice of Exercise by facsimile copy, and the payment of the aggregate
Exercise Price and the payment of all taxes required to be paid by the Holder
prior to the issuance of the Warrant Shares pursuant to Section 3, if any,
the Warrant Shares so purchased shall be and be deemed to be issued to such
Holder as the record owner of such shares as of the close of business on the
later of the date of such surrender, delivery or payment.

     

    10. Loss, Theft, Destruction or
Mutilation of Warrant.  The Company covenants that upon receipt
by the Company of evidence reasonably satisfactory to it of the loss, theft,
destruction or mutilation of this Warrant or any stock certificate relating to
the Warrant Shares, and in case of loss, theft or destruction, of indemnity or
security reasonably satisfactory to it (which, in the case of the Warrant, shall
not include the posting of any bond), and upon surrender and cancellation of
such Warrant or stock certificate, if mutilated, the Company will make and
deliver a new Warrant or stock certificate of like tenor and dated as of such
cancellation, in lieu of such Warrant or stock certificate.

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    11. Saturdays, Sundays,
Holidays, Etc.  If the last or appointed day for the taking of
any action or the expiration of any right required or granted herein shall not
be a Business Day, then such action may be taken or such right may be exercised
on the next succeeding Business Day.

     

    12. Adjustments to Exercise
Price and Number of Warrant Shares.  The number and kind of
securities purchasable upon the exercise of this Warrant and the Exercise Price
shall be subject to adjustment from time to time if the Company
shall:  (i) pay a dividend in Series G Preferred Shares or make a
distribution in shares Series G Preferred Shares to holders of its outstanding
Series G Preferred Shares; (ii) subdivide its outstanding shares of Series G
Preferred Shares into a greater number of shares; (iii) combine its outstanding
shares of Series G Preferred Shares into a smaller number of shares of Series G
Preferred Shares; or (iv) issue any shares of its capital stock in a
reclassification of the Series G Preferred Shares.  Upon the happening
of any of the events set forth in subsections (i)-(iv) of this
Section 12, the number of Warrant Shares purchasable upon exercise of this
Warrant immediately prior thereto shall be adjusted so that the Holder shall be
entitled to receive the kind and number of Warrant Shares or other securities of
the Company which it would have owned or have been entitled to receive had such
Warrant been exercised in advance thereof.  Upon each such adjustment
of the kind and number of Warrant Shares or other securities of the Company
which are purchasable hereunder, the Holder shall thereafter be entitled to
purchase the number of Warrant Shares or other securities resulting from such
adjustment at an Exercise Price per Warrant Share or other security obtained by
multiplying the Exercise Price in effect immediately prior to such adjustment by
the number of Warrant Shares purchasable pursuant hereto immediately prior to
such adjustment and dividing by the number of Warrant Shares or other securities
of the Company that are purchasable pursuant hereto immediately after such
adjustment.  An adjustment made pursuant to this paragraph shall
become effective immediately after the effective date of such event retroactive
to the record date, if any, for such event.

     

    13. Reorganization,
Reclassification, Merger, Consolidation or Disposition of
Assets.  In case the Company shall reorganize its capital,
reclassify its capital stock, consolidate or merge with or into another
corporation (where the Company is not the surviving corporation or where there
is a change in or distribution with respect to the Series G Preferred Shares of
the Company), or sell, transfer or otherwise dispose of its property, assets or
business to another corporation and, pursuant to the terms of such
reorganization, reclassification, merger, consolidation or disposition of
assets, shares of common stock of the successor or acquiring corporation, or any
cash, shares of stock or other securities or property of any nature whatsoever
(excluding cash but including warrants or other subscription or purchase rights)
in addition to or in lieu of common stock of the successor or acquiring
corporation (“Other
Property”), are to be received by or distributed to the holders of Series
G Preferred Shares of the Company, then the Holder shall have the right
thereafter to receive the number of Series G Preferred Shares of the successor
or acquiring corporation or of the Company, if it is the surviving corporation,
and Other Property receivable upon or as a result of such reorganization,
reclassification, merger, consolidation or disposition of assets by a Holder of
the number of Series G Preferred Shares for which this Warrant is exercisable
immediately prior to such event. For purposes of this
Section 13, “common stock of the successor or acquiring corporation” shall
include stock of such corporation of any class which is not preferred as to
dividends or assets over any other class of stock of such corporation and which
is not subject to redemption and shall also include any evidences of
indebtedness, shares of stock or other securities which are convertible into or
exchangeable for any such stock, either immediately or upon the arrival of a
specified date or the happening of a specified event and any warrants or other
rights to subscribe for or purchase any such stock.  The foregoing
provisions of this Section 13 shall similarly apply to successive
reorganizations, reclassifications, mergers, consolidations or disposition of
assets.

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

    14. Voluntary Adjustment by the
Company.  The Company may at any time during the term of this
Warrant reduce the then current Exercise Price to any amount and for any period
of time deemed appropriate by the Board of Directors of the
Company.

     

    15. Notice of
Adjustment.  Whenever the number of Warrant Shares or number or
kind of securities or other property purchasable upon the exercise of this
Warrant or the Exercise Price is adjusted, as herein provided, the Company shall
give notice thereof to the Holder, which notice shall state the number of
Warrant Shares (and other securities or property) purchasable upon the exercise
of this Warrant and the Exercise Price of such Warrant Shares (and other
securities or property) after such adjustment, setting forth a brief statement
of the facts requiring such adjustment and setting forth the computation by
which such adjustment was made.

     

    16. Notice of Corporate
Action.  If at any time:

     

    (a) the
Company shall take a record of the holders of its Series G Preferred Shares for
the purpose of entitling them to receive a dividend or other distribution, or
any right to subscribe for or purchase any evidences of its indebtedness, any
shares of stock of any class or any other securities or property, or to receive
any other right, or

     

    (b) there
shall be any capital reorganization of the Company, any reclassification or
recapitalization of the capital stock of the Company or any consolidation or
merger of the Company with, or any sale, transfer or other disposition of all or
substantially all the property, assets or business of the Company to, another
corporation or,

     

    (c) there
shall be a voluntary or involuntary dissolution, liquidation or winding up of
the Company;

     

    then, in
any one or more of such cases, the Company shall give to Holder: (i) at least 20
days’ prior written notice of the date on which a record date shall be selected
for such dividend, distribution or right or for determining rights to vote in
respect of any such reorganization, reclassification, merger, consolidation,
sale, transfer, disposition, liquidation or winding up, and (ii) in the case of
any such reorganization, reclassification, merger, consolidation, sale,
transfer, disposition, dissolution, liquidation or winding up, at least 20 days’
prior written notice of the date when the same shall take place.  Such
notice in accordance with the foregoing clause also shall specify: (A) the date
on which any such record is to be taken for the purpose of such dividend,
distribution or right, the date on which the holders of Series G Preferred
Shares shall be entitled to any such dividend, distribution or right, and the
amount and character thereof, and (B) the date on which any such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition,
dissolution, liquidation or winding up is to take place and the time, if any
such time is to be fixed, as of which the holders of Series G Preferred Shares
shall be entitled to exchange their Warrant Shares for securities or other
property deliverable upon such disposition, dissolution, liquidation or winding
up.  Each such written notice shall be sufficiently given if addressed
to Holder at the last address of Holder appearing on the books of the Company
and delivered in accordance with Section 19(d).

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

    17. Authorized
Shares.  The Company covenants that during the period the
Warrant is outstanding, it will reserve from its authorized and unissued Series
G Preferred Shares a sufficient number of shares to provide for the issuance of
the Warrant Shares upon the exercise of any purchase rights under this
Warrant.  The Company further covenants that its issuance of this
Warrant shall constitute full authority to its officers who are charged with the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant.  The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided
herein without violation of any applicable law or regulation.

     

    Except
and to the extent as waived or consented to by the Holder, the Company shall not
by any action, including, without limitation, amending the Company’s Articles of
Incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all
such terms and in the taking of all such actions as may be necessary or
appropriate to protect the rights of Holder as set forth in this Warrant against
impairment.  Without limiting the generality of the foregoing, the
Company will: (i) not increase the par value of any Warrant Shares above the
amount payable therefor upon such exercise immediately prior to such increase in
par value, (ii) take all such action as may be necessary or appropriate in order
that the Company may validly and legally issue fully paid and nonassessable
Warrant Shares upon the exercise of this Warrant, and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents
from any public regulatory body having jurisdiction thereof as may be necessary
to enable the Company to perform its obligations under this
Warrant.

     

    Before
taking any action which would result in an adjustment in the number of Warrant
Shares for which this Warrant is exercisable or in the Exercise Price, the
Company shall obtain all such authorizations or exemptions thereof, or consents
thereto, as may be necessary from any public regulatory body or bodies having
jurisdiction thereof.

     

    18. Miscellaneous.

     

    (a) This
Warrant shall be governed by and construed in accordance with the laws of the
State of Washington without regard to principles of conflict of
laws.

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

    (b) The
Holder acknowledges that the Warrant Shares acquired upon the exercise of this
Warrant, if not registered, will have restrictions upon resale imposed by state
and federal securities laws.

     

    (c) No course
of dealing or any delay or failure to exercise any right hereunder on the part
of Holder shall operate as a waiver of such right or otherwise prejudice
Holder’s rights, powers or remedies, notwithstanding all rights hereunder
terminate on the Termination Date.  If the Company willfully and
knowingly fails to comply with any provision of this Warrant, which results in
any material damages to the Holder, the Company shall pay to Holder such amounts
as shall be sufficient to cover any costs and expenses including, but not
limited to, reasonable attorneys’ fees, including those of appellate
proceedings, incurred by Holder in collecting any amounts due pursuant hereto or
in otherwise enforcing any of its rights, powers or remedies
hereunder.

     

    (d) All
notices, requests, consents and other communications hereunder shall be in
writing and shall be deemed to have been made when delivered or mailed by first
class mail, postage prepaid, as follows:  (a) if to the Holder,
at the address of the Holder as shown on the registry books maintained by the
Company or the Transfer Agent; and (b) if to the Company, at 430 N. Carroll
Avenue, Suite 120, Southlake, Texas 76092, Attention: Chief Executive
Officer.

     

    (e) No
provision hereof, in the absence of any affirmative action by Holder to exercise
this Warrant or purchase Warrant Shares, and no enumeration herein of the rights
or privileges of Holder, shall give rise to any liability of Holder for the
purchase price of any Series G Preferred Shares or as a shareholder of the
Company, whether such liability is asserted by the Company or by creditors of
the Company.

     

    (f) Holder,
in addition to being entitled to exercise all rights granted by law, including
recovery of damages, will be entitled to specific performance of its rights
under this Warrant.  The Company agrees that monetary damages would
not be adequate compensation for any loss incurred by reason of a breach by it
of the provisions of this Warrant and hereby agrees to waive the defense in any
action for specific performance that a remedy at law would be
adequate.

     

    (g) Subject
to applicable securities laws, this Warrant and the rights and obligations
evidenced hereby shall inure to the benefit of and be binding upon the
successors of the Company and the successors and permitted assigns of
Holder.  The provisions of this Warrant are intended to be for the
benefit of all Holders from time to time of this Warrant and shall be
enforceable by any such Holder or holder of Warrant Shares.

     

    (h) This
Warrant may be modified or amended or the provisions hereof waived with the
written consent of the Company and the Holder.

     

    (i) Wherever
possible, each provision of this Warrant shall be interpreted in such manner as
to be effective and valid under applicable law, but if any provision of this
Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without
invalidating the remainder of such provisions or the remaining provisions of
this Warrant.

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

    (j) The
headings used in this Warrant are for the convenience of reference only and
shall not, for any purpose, be deemed a part of this Warrant.

     

    

     

    

     

    Signature
on following page.

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

    IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its officer thereunto duly
authorized.

     

     

     

    
      	
              Dated:  March
      5, 2010

               

            	 	 GEOS
      COMMUNICATIONS, INC.
	 	 By:	 
	
                                                                                   

               

               

            	 	
               Christopher
      Miltenberger

               President
      and Chief Operating Officer

            

    

     

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

    EXHIBIT
A

     

    ASSIGNMENT
FORM

     

    (To
assign the foregoing warrant, execute this form

    and
supply required information.

    Do not
use this form to exercise the warrant.)

     

    FOR VALUE
RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby
assigned to _______________________________________________ whose address is
_______________________________________________________________.

     

    
      	 	 Dated:  ______________,
      _______

    

     

    
       

      
        	 	 Holder’s
      Signature:	 	 
	 	 	 	 
	 	 Holder’s
      Address:	 	 
	 	 	 	 
	 	 	 	 

      

    

     

     

    Signature
Guaranteed: ______________________________________________

     

    NOTE:  The
signature to this Assignment Form must correspond with the name as it appears on
the face of the Warrant, without alteration or enlargement or any change
whatsoever, and must be guaranteed by a bank or trust
company.  Officers of corporations and those acting in a fiduciary or
other representative capacity should file proper evidence of authority to assign
the foregoing Warrant.

     

    
      
        
        

      

      
        A-1

        
          

        

      

      
        
        

      

    

    EXHIBIT
B

     

    NOTICE OF
EXERCISE

     

    To:           Geos
Communications, Inc.

     

    The
undersigned, the Holder of the attached Warrant, hereby irrevocably elects to
exercise the purchase right represented by the Warrant for, and to purchase
thereunder, _______ Series G Preferred Shares (as such terms are defined in the
Warrant, dated ____________, 2010, issued by Geos Communications, Inc. to
_________________).

     

    
      	
               
      

            	
              �

            	
              (Cash
      Exercise)  The undersigned has included with this Form of
      Subscription the purchase price of such shares in
  full.

            

    

     

    
      	
               
      

            	
              �

            	
              (Cashless
      Exercise)  The undersigned elects to purchase such shares
      pursuant to the net exercise provisions of such
  Warrant.

            

    

     

    The
undersigned hereby requests that the Certificate(s) for such securities be
issued in the name(s) and delivered to the address(es) as follows:

    
    

     

    
      	Name:	 
	 	 
	Address:	 
	 	 
	Social Security
      Number:	 
	 	 
	Deliver
to:	 
	 	 
	Address:	 

    

     

    If the
foregoing Subscription evidences an exercise of the Warrant to purchase fewer
than all of the Warrant Shares (or other securities or property) to which the
undersigned is entitled under such Warrant, please issue a new Warrant, of like
tenor, for the remaining portion of the Warrant (or other securities or
property) in the name(s), and deliver the same to the address(es) as
follows:

    
    

     

    
      	Name:	 
	 	 
	Address:	 
	 	 
	Dated:	____________,
      20___.

    

     

    
    

     

    
      	 	 	 
	(Name of
      Holder)	 	 
	 	 	 
	 	 	 
	(Signature of Holder
      or Authorized Signatory)	 	(SS or TIN of
      Holder)
	 	 	 
	 	 	 
	Signature
      Guaranteed:	 	 
	 	 	 
	 	 	 

    

     

     

    
      
        
        

      

      
        B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}]]